ABIVAX Société Anonyme (AAVXF)
OTCMKTS · Delayed Price · Currency is USD
120.85
0.00 (0.00%)
Feb 10, 2026, 4:00 PM EST
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $9.07 billion as of February 11, 2026. Its market cap has increased by 2,179.63% in one year.
Market Cap
9.07B
Enterprise Value
8.46B
Revenue
6.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
$120.85
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 225.47M to 9.07B, an increase of 3,922.03%. That is a compound annual growth rate of 41.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 9.35B | -14.97% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |